ImmunityBio Presents New Clinical and Comparative Data Across Lung and Bladder Cancer at ASCO 2026
Go back to ImmunityBio Presents New Clinical and Comparative Data Across Lung and Bladder Cancer at ASCO 2026| (NASDAQ: IBRX) | Delayed: 7.22 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.22 | 52 Week High | $ | |||
| Open | $7.22 | 52 Week Low | $ | |||
| Day High | $7.22 | P/E | N/A | |||
| Day Low | $7.22 | EPS | $ | |||
| Volume | 100,987 | |||||
